TSLP and asthma: Studies carried out on severe asthma have identified specific characteristics linked to the T2-prevalent “component” of the disease: the involvement of ILC2 and of cytokines called alarmins (TSLP, IL-25, IL-23), as early effectors in response to the possible epithelial damage.